Publications by authors named "Rodolphe Hajj"

Claim this Profile
C
Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer's Disease.
Serguei Nabirotchkin, Jan Bouaziz, Fabrice Glibert, Jonas Mandel, Julie Foucquier, Rodolphe Hajj

J Alzheimers Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An overview of ongoing clinical trials assessing pharmacological therapeutic strategies to manage chemotherapy-induced peripheral neuropathy, based on preclinical studies in rodent models.
Hichem Bouchenaki, Aurore Danigo, Franck Sturtz, Rodolphe Hajj, Laurent Magy

Fundam Clin Pharmacol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis.
Lydie Boussicault, Julien Laffaire, Peter Schmitt, Philippe Rinaudo, Noëlle Callizot, Rodolphe Hajj

J Neurosci Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) rats.
Thomas Prukop, Stephanie Wernick, Lydie Boussicault, David Ewers, Karoline Jäger, Rodolphe Hajj

J Neurosci Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation drug repurposing using human genetics and network biology.
Serguei Nabirotchkin, Alex E Peluffo, Philippe Rinaudo, Jinchao Yu, Rodolphe Hajj

Curr Opin Pharmacol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pharmacological management of neuropathic pain].
Hichem Bouchenaki, Mélina Bégou, Laurent Magy, Rodolphe Hajj, Claire Demiot

Therapie· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A).
Thomas Prukop, Jan Stenzel, Stephanie Wernick, Theresa Kungl, Magdalena Mroczek, Rodolphe Hajj

PLoS One· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular changes in the postmortem parkinsonian brain.
Damien Toulorge, Anthony H V Schapira, Rodolphe Hajj

J Neurochem· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.
Shahram Attarian, Jean-Michel Vallat, Laurent Magy, Benoît Funalot, Pierre-Marie Gonnaud, Rodolphe Hajj

Orphanet J Rare Dis· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease.
Rodolphe Hajj, Aude Milet, Damien Toulorge, Nathalie Cholet, Julien Laffaire

Sci Rep· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy.
Ilya Chumakov, Serguei Nabirotchkin, Nathalie Cholet, Aude Milet, Aurélie Boucard, Rodolphe Hajj

Sci Rep· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
Ilya Chumakov, Aude Milet, Nathalie Cholet, Gwenaël Primas, Aurélie Boucard, Rodolphe Hajj

Orphanet J Rare Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.
Shahram Attarian, Jean-Michel Vallat, Laurent Magy, Benoît Funalot, Pierre-Marie Gonnaud, Rodolphe Hajj

Orphanet J Rare Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trefoil factor family 3 peptide promotes human airway epithelial ciliated cell differentiation.
Pierre LeSimple, Isabelle van Seuningen, Marie-Pierre Buisine, Marie-Christine Copin, Margitta Hinz, Rodolphe Hajj

Am J Respir Cell Mol Biol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basal cells of the human adult airway surface epithelium retain transit-amplifying cell properties.
Rodolphe Hajj, Thomas Baranek, Richard Le Naour, Pierre Lesimple, Edith Puchelle

Stem Cells· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Repair and regeneration of the airway epithelium].
Christelle Coraux, Rodolphe Hajj, Pierre Lesimple, Edith Puchelle

Med Sci (Paris)· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential expression of matrix metalloproteinases and interleukin-8 during regeneration of human airway epithelium in vivo.
Christelle Coraux, Corinne Martinella-Catusse, Béatrice Nawrocki-Raby, Rodolphe Hajj, Henriette Burlet

J Pathol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis